mutLBSgeneDB

mutLBSgeneDB
mutated Ligand Binding Site gene DataBase

Home

Download

 Statistics

Help

About Us

Bioinformatics and Systems Medicine Laboratory Bioinformatics and Systems Medicine Laboratory

Gene Summary

Ligand Binding Site Mutation Information

Protein Structure Related Information

Gene Expression and Gene-Gene Network

Phenotype Information

Pharmacological Information

Conservation Information for LBS

Gene summary for FLT3LG
Gene summary
Basic gene Info.Gene symbolFLT3LG
Gene namefms-related tyrosine kinase 3 ligand
SynonymsFL|FLT3L
CytomapUCSC genome browser: 19q13.3
Type of geneprotein-coding
RefGenesNM_001204502.1,
NM_001204503.1,NM_001278637.1,NM_001278638.1,NM_001459.3,
Descriptionflt3 ligand
Modification date20141207
dbXrefs MIM : 600007
HGNC : HGNC
Ensembl : ENSG00000090554
HPRD : 02477
Vega : OTTHUMG00000186490
ProteinUniProt: P49771
go to UniProt's Cross Reference DB Table
ExpressionCleanEX: HS_FLT3LG
BioGPS: 2323
PathwayNCI Pathway Interaction Database: FLT3LG
KEGG: FLT3LG
REACTOME: FLT3LG
Pathway Commons: FLT3LG
ContextiHOP: FLT3LG
ligand binding site mutation search in PubMed: FLT3LG
UCL Cancer Institute: FLT3LG
Assigned class in mutLBSgeneDBC: This gene just belongs to mutLBSgenes.

Gene ontology having evidence of Inferred from Direct Assay (IDA) from Entrez
GO IDGO TermPubMed ID
GO:0008284positive regulation of cell proliferation8180375
GO:0035162embryonic hemopoiesis21149635


Top
Ligand binding site mutations for FLT3LG

Cancer type specific mutLBS sorted by frequency
LBSAAchange of nsSNVCancer type# samples
K44,D40A42TCOAD1
cf) Cancer type abbreviation. BLCA: Bladder urothelial carcinoma, BRCA: Breast invasive carcinoma, CESC: Cervical squamous cell carcinoma and endocervical adenocarcinoma, COAD: Colon adenocarcinoma, GBM: Glioblastoma multiforme, LGG: Brain lower grade glioma, HNSC: Head and neck squamous cell carcinoma, KICH: Kidney chromophobe, KIRC: Kidney renal clear cell carcinoma, KIRP: Kidney renal papillary cell carcinoma, LAML: Acute myeloid leukemia, LUAD: Lung adenocarcinoma, LUSC: Lung squamous cell carcinoma, OV: Ovarian serous cystadenocarcinoma, PAAD: Pancreatic adenocarcinoma, PRAD: Prostate adenocarcinoma, SKCM: Skin cutaneous melanoma, STAD: Stomach adenocarcinoma, THCA: Thyroid carcinoma, UCEC: Uterine corpus endometrial carcinoma.


Top
Protein structure related information for FLT3LG
Relative protein structure stability change (ΔΔE) using Mupro 1.1
Mupro score denotes assessment of the effect of mutations on thermodynamic stability.
  (ΔΔE<0: mutation decreases stability, ΔΔE>0: mutation increases stability)
: nsSNV at non-LBS: nsSNV at LBS

nsSNVs sorted by the relative stability change of protein structure by each mutation
Blue: mutations of positive stability change. and red : the most recurrent mutation for this gene.
LBSAAchange of nsSNVRelative stability change
K44A42T-1.3098449
D40A42T-1.3098449
(MuPro1.1: Jianlin Cheng et al., Prediction of Protein Stability Changes for Single-Site Mutations Using Support Vector Machines, PROTEINS: Structure, Function, and Bioinformatics. 2006, 62:1125-1132)

Structure image for FLT3LG from PDB

Top
Differential gene expression and gene-gene network for FLT3LG
Differential gene expression between mutated and non-mutated LBS samples in all 16 major cancer types

Differential co-expressed gene network based on protein-protein interaction data (CePIN)
* Left PPI network was created from samples with mutations in the LBS of FLT3LG and the right PPI network was created from samples without mutations in the LBS of FLT3LG. Only genes with p-value < 0.05 are shown.
Red circle: input gene. Orange circle: LBSgene. Blue circle: other gene.


Top

Top
Phenotype information for FLT3LG
Gene level disease information (DisGeNet)
Disease IDDisease name# PubMedAssociation type

Mutation level pathogenic information (ClinVar annotation)
Allele IDAA changeClinical significanceOriginPhenotype IDs

Top
Pharmacological information for FLT3LG
Gene expression profile of anticancer drug treated cell-lines (CCLE)
Heatmap showing the correlation between gene expression and drug response across all the cell-lines. We chose the top 20 among 138 drugs.We used Pearson's correlation coefficient.
Drug information targeting mutLBSgene (Approved drugs only)
Drug statusDrugBank IDNameTypeDrug structure

Gene-centered ligand-gene interaction network

Ligands binding to mutated ligand binding site of FLT3LG go to BioLip
Ligand IDLigand short nameLigand long namePDB IDPDB namemutLBS
ZNZINC(2+)1eteBD40


Top
Conservation information for LBS of FLT3LG
Multiple alignments for P49771 in multiple species
LBSAA sequence# speciesSpecies


Copyright © 2016-Present - The University of Texas Health Science Center at Houston
Site Policies | State of Texas